EUVIMEDEUVIMED entdecken
Crossref

Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides

Nihar R Desai iD, Katalin Bognar iD, Amanda Speller iD, Ashis K Das iD

Journal of Comparative Effectiveness Research · 18.11.2026

DOI: 10.57264/cer-2026-0095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, online erschienen am 18.11.2026. Verfasst von Nihar R Desai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, 333 Cedar St., New Haven, CT 06510, USA. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: Familial chylomicronemia syndrome (FCS) is a rare disorder caused by severe hypertriglyceridemia which increases risk for life-threatening acute pancreatitis (AP). The aim of this study was to indirectly compare the effectiveness of two novel triglyceride (TG)-lowering APOC3 RNA inhibitors in these patients. Materials & methods: An individual patient simulation model was developed and implemented using Monte Carlo sampling to assess the impact of novel FCS treatments, plozasiran versus olezarsen, on serum TG levels. Patient-level heterogeneity was captured through a distribution of pre-treatment TG levels matching the PALISADE trial cohort in the base case. Uncertainty in treatment response (percent reduction of TG levels) was modeled using beta distributions with parameters based on the pivotal PALISADE and BALANCE trials for plozasiran and olezarsen, respectively. The proportion of patients who achieved TG levels of

Schlagwörter

Stichwörter der Autor:innen

APOC3 inhibitorsMonte Carlo methodacute pancreatitisfamilial chylomicronemia syndromehypertriglyceridemiamicrosimulationolezarsenplozasirantriglycerides

Autor:innen und Institutionen

  • Yale School of Medicine, 333 Cedar St., New Haven, CT 06510, USA.
  • ADVI Health, LLC, 1000 F St. NW, Suite 650, Washington, DC 20004, USA.

ORCID-Profile: Nihar R Desai, Katalin Bognar, Amanda Speller, Ashis K Das

Zitieren

APA

Desai, N. R., Bognar, K., Speller, A., & Das, A. K. (2026). Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2026-0095

Vancouver

Desai NR, Bognar K, Speller A, Das AK. Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides. Journal of Comparative Effectiveness Research. 2026. doi:10.57264/cer-2026-0095

BibTeX
@article{Desai2026,
  author = {Desai, Nihar R and Bognar, Katalin and Speller, Amanda and Das, Ashis K},
  title = {Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2026},
  doi = {10.57264/cer-2026-0095}
}
Kostenlos starten →